🇺🇸 FDA
Pipeline program

Isotone Natriumchloridlösung 0,9 % Braun Injektionslösung, JNJ-80202135, JNJ-80202135

MOM-M281-006

Phase 3 small_molecule active

Quick answer

Isotone Natriumchloridlösung 0,9 % Braun Injektionslösung, JNJ-80202135, JNJ-80202135 for Warm Autoimmune Hemolytic Anemia is a Phase 3 program (small_molecule) at Janssen-Cilag International N.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Janssen-Cilag International N.V.
Indication
Warm Autoimmune Hemolytic Anemia
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials